Potential approval delayed for Sarepta's Duchenne drug; shares plunge
October 27, 2014 at 10:37 AM EDT
Duchenne muscular dystrophy patients and their families were delivered a heartbreaking setback this morning when Sarepta Therapeutics, which is developing a treatment to slow the progression of the disease, said it won't file for approval for several months later than hoped...